UTI Healthcare Fund Direct Growth

UTI Healthcare Fund Direct Growth

Equity

UTI Mutual Fund

Sector - Healthcare

Get the latest NAV of UTI Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹300.12

▲0.7%1D

NAV as on 12 May 2025

16.05%/per year

Since Inception

Absolute Gain%

▲▼

309 people have invested ₹ 22.1L in UTI Healthcare Fund Direct Growth in the last three months

UTI Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (12-May-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
2.59%
8.47%
3.21%
3 Months
1.64%
7.67%
1.68%
6 Months
-5.11%
0.81%
-3.86%
1 Year
21.85%
9.98%
18.38%
3 Years
24.48%
18.69%
22.56%
5 Years
23.11%
24.52%
21.85%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
UTI Healthcare Fund
7/8
1,037Cr
1.2%
21.85%
24.48%
16.05%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,671Cr
0.9%
22.04%
28.99%
18.15%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
3/8
4,915Cr
1.18%
23.79%
28.39%
22.38%
DSP Healthcare Fund Direct Growth
4/8
2,912Cr
0.63%
13.56%
24.86%
24.03%
See all
img
Beats FD returns for both 3Y & 5Y duration
img
5Y returns in the bottom 25% of the category

UTI Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

UTI Healthcare Fund Asset Allocation

as on (31-Mar-25)

Fund Distribution

as on (31-Mar-25)

Equity 98.9%

Debt & Cash 1.1%

Small cap
41.1%
Large cap
28.9%
Mid cap
28%
Mid Cap allocation has gone up from 26.3% to 27.8%
Mid Cap allocation has gone up from 26.3% to 27.8%
Large Cap allocation has gone up from 28.9% to 28.9%
Large Cap allocation has gone up from 28.9% to 28.9%
Small Cap allocation has gone down from 43.5% to 41.5%
Small Cap allocation has gone down from 43.5% to 41.5%
Cash allocation has gone up from 0.4% to 0.8%
Cash allocation has gone up from 0.4% to 0.8%

UTI Healthcare Fund Sector Allocation

as on (31-Mar-25)

Sector Allocation

Equity 98.9%

Debt & Cash 1.1%

Health
98.4%
Basic Materials
1.3%
Financial Services
0.3%

Top 2 Sectors in March were Health, Basic Materials

Mar'25

Health

99%

Basic Materials

1%

Feb'25

Health

99%

Basic Materials

1%

UTI Healthcare Fund Holdings Details

as on (30-Apr-25)

Equity

Holdings
Weight%
1M Change
Sun Pharmaceuticals Industries Ltd
11.88%
-3.4%
Cipla Ltd
5.98%
-9.7%
Dr Reddy's Laboratories Ltd
4.52%
-8.5%
Ajanta Pharma Ltd
4.51%
-7.2%
Procter & Gamble Health Ltd
3.91%
0%
See all
Top Stocks bought last month
Sun Pharmaceuticals Industries Ltd's allocation increased from 10.93% to 11.65%
Sun Pharmaceuticals Industries Ltd's allocation increased from 10.93% to 11.65%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 1.87% to 2.27%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 1.87% to 2.27%
Apollo Hospitals Enterprise Ltd's allocation increased from 3.22% to 3.57%
Apollo Hospitals Enterprise Ltd's allocation increased from 3.22% to 3.57%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 6.19 % to 5.81 %
Cipla Ltd's allocation decreased from 6.19 % to 5.81 %
Ajanta Pharma Ltd's allocation decreased from 4.43 % to 4.4 %
Ajanta Pharma Ltd's allocation decreased from 4.43 % to 4.4 %
Dr Reddy's Laboratories Ltd's allocation decreased from 4.89 % to 4.35 %
Dr Reddy's Laboratories Ltd's allocation decreased from 4.89 % to 4.35 %

UTI Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio1.2%
Benchmark
BSE Healthcare TR INR
AUM₹1037 Cr
Inception Date1 January, 2013
Min Lumpsum/SIP₹5000/₹500
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
24.75%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About UTI Healthcare Fund

UTI Healthcare Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by . The fund could potentially beat inflation in the long-run.

Key Parameters

  1. UTI Healthcare Fund Direct Growth has ₹1037 Cr worth of assets under management (AUM) as on Mar 2025 and is less than category average.
  2. The fund has an expense ratio 1.2.

Returns

UTI Healthcare Fund Direct Growth has given a CAGR return of 16.05% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 21.85%, 24.48% and 23.11% respectively.

Holdings

UTI Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Ajanta Pharma Ltd, Procter & Gamble Health Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of UTI Healthcare Fund Direct Growth

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. UTI Healthcare Fund Direct Growth has no lock in period.

Learn more about UTI Mutual Fund
Parameters
Mar'25
Feb'25
Jan'25
AUM
₹ 1K Cr
₹ 1.1K Cr
₹ 1.2K Cr
  • AUM of the fund stands at 1K Cr as of Mar'25
  • AUM decreased by 15.1 Cr between Mar'25 and Feb'25

Most Popular Comparisons

UTI Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for UTI Healthcare Fund Direct Growth

What is the current NAV of UTI Healthcare Fund Direct Growth?

The current NAV of UTI Healthcare Fund Direct Growth is ₹300.12 as on 12-May-2025.

What are the average returns of UTI Healthcare Fund Direct Growth?

Existing (Absolute + CAGR) as on 12-May-2025.
UTI Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
2.59%
2.59%
6 Month Returns
-5.11%
-5.11%
1 Year Returns
21.85%
21.85%
3 Years Returns
92.86%
24.48%

How do I invest in UTI Healthcare Fund Direct Growth?

With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.

What is the expense ratio of UTI Healthcare Fund Direct Growth?

1.2% as on April 2025

What is net assets under management (AUM) of UTI Healthcare Fund Direct Growth?

₹1037 Cr as on April 2025

What are the top 5 holdings of UTI Healthcare Fund Direct Growth?

Sun Pharmaceuticals Industries Ltd(11.88%), Cipla Ltd(5.98%), Dr Reddy's Laboratories Ltd(4.52%), Ajanta Pharma Ltd(4.51%), Procter & Gamble Health Ltd(3.91%) as on April 2025

What is the alpha of UTI Healthcare Fund Direct Growth?

The alpha ratio for the UTI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
UTI Healthcare Fund Direct Growth
1.57
0.99
0.7
As on April 2025
The alpha for UTI Healthcare Fund Direct Growth is calculated against BSE Healthcare TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.

What is the beta of UTI Healthcare Fund Direct Growth??

The Beta ratio for the UTI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
UTI Healthcare Fund Direct Growth
1.01
0.95
0.96
As on April 2025
The Beta for UTI Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.

What is the sharpe ratio of UTI Healthcare Fund Direct Growth?

The sharpe ratio for the UTI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
UTI Healthcare Fund Direct Growth
0.74
0.87
1.04
As on April 2025
The sharpe ratio for UTI Healthcare Fund Direct Growth is calculated with BSE Healthcare TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.

What is the standard deviation of UTI Healthcare Fund Direct Growth?

The standard deviation for the UTI Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
UTI Healthcare Fund Direct Growth
20.52
16.65
16.46
As on April 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.

What is the Sortino ratio of UTI Healthcare Fund Direct Growth?

Sortino ratio is 1.54 as on April 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.

What is the information ratio of UTI Healthcare Fund Direct Growth?

Information ratio is 0.16 as on April 2025. It tells the consistency of the fund in generating superior risk-adjusted performance

What is the exit load of UTI Healthcare Fund Direct Growth?

The Exit load of UTI Healthcare Fund Direct Growth is 1%